<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="373">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02811653</url>
  </required_header>
  <id_info>
    <org_study_id>PI2015_843_0003</org_study_id>
    <nct_id>NCT02811653</nct_id>
  </id_info>
  <brief_title>Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease</brief_title>
  <acronym>TAMA</acronym>
  <official_title>Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In AD (Alzheimer disease), the anatomic correlates of attention disorders (as evaluated by&#xD;
      motor slowing) have not been thoroughly characterized.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>median SRT (simple reaction time) to a stimulus (in milliseconds)</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">155</enrollment>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>Alzheimer disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Alzheimer disease patients Brain MRI (Magnetic Resonance Imaging) Blood neuropsychological evaluation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy age- and gender-matched volunteers will be recruited into the study from the general population.&#xD;
Brain MRI (Magnetic Resonance Imaging) Blood neuropsychological evaluation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Brain MRI</intervention_name>
    <arm_group_label>Alzheimer disease</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>neuropsychological evaluation</intervention_name>
    <arm_group_label>Alzheimer disease</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood</intervention_name>
    <arm_group_label>Alzheimer disease</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients&#xD;
&#xD;
               -  Age between 40 and 85&#xD;
&#xD;
               -  French mother tongue&#xD;
&#xD;
               -  Consulting at the Amiens Memory Resource and Research Centre (CMRR) for:&#xD;
&#xD;
               -  MCI, according to Albert et al.'s criteria (Albert et al., 2011)&#xD;
&#xD;
               -  Mild dementia (MMSE&gt;20) due to AD, according to McKhann's criteria (McKhann et&#xD;
                  al., 2011).&#xD;
&#xD;
               -  Mild dementia due to LBD, according to McKeith et al.'s criteria (McKeith et al.,&#xD;
                  2005).&#xD;
&#xD;
               -  Mild dementia due to FTLD, according to Rascovsky et al.'s criteria (Rascovsky et&#xD;
                  al., 2011).&#xD;
&#xD;
               -  Social security coverage&#xD;
&#xD;
          -  Healthy controls&#xD;
&#xD;
               -  Healthy age and gender matched volunteers will be recruited into the study from&#xD;
                  the general population.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Reading or writing difficulties related to a learning disorder or illiteracy.&#xD;
&#xD;
          -  A medical history with a potentially significant impact on cognition (non-corrected&#xD;
             thyroid disorders or heart failure):&#xD;
&#xD;
               -  NYHA stage IV dyspnoea.&#xD;
&#xD;
               -  respiratory impairment requiring oxygen therapy.&#xD;
&#xD;
               -  liver impairment.&#xD;
&#xD;
               -  kidney failure, progressing neoplastic disease, or past or present alcohol abuse.&#xD;
&#xD;
          -  Past or present neurological disorders other than those having prompted consultation&#xD;
             in the Memory Clinic:&#xD;
&#xD;
               -  stroke.&#xD;
&#xD;
               -  meningitis or encephalitis.&#xD;
&#xD;
               -  severe head injury.&#xD;
&#xD;
               -  sensorimotor impairments (sensory, proprioceptive, cerebellar and visual&#xD;
                  impairments).&#xD;
&#xD;
               -  epilepsy (requiring ongoing treatment),&#xD;
&#xD;
               -  psychiatric disorders (other than treated depression).&#xD;
&#xD;
               -  treatment with psychotropic medications (other than anxiolytics or antidepressant&#xD;
                  withdrawn or initiated in the previous month). Patients with parkinsonian&#xD;
                  syndrome were examined in the &quot;on-drug&quot; state.&#xD;
&#xD;
          -  Impossibility to perform a neuropsychological evaluation or brain MRI.&#xD;
&#xD;
          -  Withdrawal from the study at any time, if desired.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Contra-indication to MRI:&#xD;
&#xD;
               -  nerve stimulators&#xD;
&#xD;
               -  cochlear implants&#xD;
&#xD;
               -  ferromagnetic foreign bodies close to nervous structures in the eye or brain&#xD;
&#xD;
               -  cerebral shunts&#xD;
&#xD;
               -  dental appliances&#xD;
&#xD;
          -  Legal guardianship or incarceration.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniela ANDRIUTA, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniela ANDRIUTA, PhD</last_name>
    <phone>+33 3 22 66 82 40</phone>
    <email>andriuta.daniela@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela ANDRIUTA, PhD</last_name>
      <phone>+33 3 22 66 82 40</phone>
      <email>andriuta.daniela@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <study_first_submitted>June 16, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2016</study_first_posted>
  <last_update_submitted>June 22, 2016</last_update_submitted>
  <last_update_submitted_qc>June 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Motor slowing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

